ACHL
Closed
Achilles Therapeutics Plc Adr
1.48
0.00 (0.00%)
Last Update: 26 Mar 2025 16:30:00
Yesterday: 1.48
Day's Range: 1.48 - 1.48
Send
sign up or login to leave a comment!
When Written:
0.9602
Achilles Therapeutics PLC ADR is a biopharmaceutical company that focuses on the development of personalized cancer immunotherapies. The company is based in the United Kingdom and was founded in 2016. Achilles Therapeutics utilizes its proprietary technology platform to develop T cell therapies that target patient-specific mutations in cancer cells. The company's lead product candidate, called AT-101, is currently in clinical trials for the treatment of solid tumors. Achilles Therapeutics is listed on the NASDAQ stock exchange under the ticker symbol "ACHL."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








